Insider · CIK 0001196661
Donald E Bobo Jr
officer
Files at EW (Edwards Lifesciences Corp). First filing Oct 15, 2024, latest May 27, 2026.
Donald E Bobo Jr files SEC Form 4 as officer at EW (Edwards Lifesciences Corp). Since Oct 15, 2024, Donald E Bobo Jr has reported 0 open-market buys worth $0 and 16 open-market sells worth $15M, the latest filed on May 27, 2026.
A track record needs three past buys with six months of prices behind them; Donald E Bobo Jr has 0, so none is measured yet.
The newest scored trade: sold $2.0M of EW on May 27, 2026, filed May 27, 2026, scored 60 (notable). In the last 12 months: 0 buys worth $0 and 8 sells worth $11M.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 16
$0 bought, $15M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EW: Edwards Lifesciences Corp
EWOct 9, 2026 · close 85.21
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 60Notable | Edwards Lifesciences Corp | $2.0M 23,145 shares | -19% | +19% from low-1% from high | |
| 75Notable | Edwards Lifesciences Corp | $1.5M 17,968 shares | -55% | +12% from low-7% from high | |
| 40Moderate | Edwards Lifesciences Corp | $1.8M 22,680 shares | -52% | +21% from low-7% from high | |
| 30Weak | Edwards Lifesciences Corp | $974k 11,340 shares | -35% | +30% from low0% from high | |
| 75Notable | Edwards Lifesciences Corp | $2.0M 24,000 shares | -53% | +24% from low-4% from high | |
| 23Weak | Edwards Lifesciences Corp | $971k 11,340 shares | -26% | +28% from low-1% from high | |
| 59Moderate | Edwards Lifesciences Corp | $954k 11,386 shares | -23% | +24% from low-4% from high | |
| 24Weak | Edwards Lifesciences Corp | $951k 11,340 shares | -18% | +25% from low-3% from high | |
| 22Weak | Edwards Lifesciences Corp | $199k 2,570 shares | -5% | +21% from low-0% from high | |
| 13Weak | Edwards Lifesciences Corp | $663k 9,500 shares | -17% | +8% from low-8% from high | |
| 20Weak | Edwards Lifesciences Corp | $646k 9,500 shares | -17% | - | |
| 18Weak | Edwards Lifesciences Corp | $492k 6,500 shares | -12% | - | |
| 3Weak | Edwards Lifesciences Corp | $344k 5,000 shares | -10% | - | |
| 10Weak | Edwards Lifesciences Corp | $359k 5,000 shares | -10% | - | |
| 3Weak | Edwards Lifesciences Corp | $328k 5,000 shares | -10% | - | |
| 0Weak | Edwards Lifesciences Corp | $348k 5,000 shares | -10% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 27, 2026 | EW EDWARDS LIFESCIENCES CORPORATION | 23,145 0.00% of outstanding | $2.0M | May 27, 2026 | $5.0M |
| May 15, 2026 | EW Edwards Lifesciences Corp | 9,968 0.00% of outstanding | $818k | May 15, 2026 | $4.8M |
| Feb 26, 2026 | EW EDWARDS LIFESCIENCES CORPORATION | 24,000 0.00% of outstanding | $2.0M | Feb 25, 2026 | $1.9M |
| Jan 6, 2026 | EW Edwards Lifesciences Corp | 45,360 0.01% of outstanding | $3.9M | Jan 6, 2026 | $1.9M |
| Dec 12, 2025 | EW Edwards Lifesciences Corp | 5,487 0.00% of outstanding | $460k | Dec 12, 2025 | $951k |
| Dec 12, 2025 | EW EDWARDS LIFESCIENCES CORPORATION | 5,900 0.00% of outstanding | $494k | Dec 12, 2025 | none |
| Dec 10, 2025 | EW Edwards Lifesciences Corp | 11,340 0.00% of outstanding | $951k | Dec 10, 2025 | none |
| Jun 2, 2025 | EW Edwards Lifesciences Corp | 2,570 0.00% of outstanding | $199k | Jun 2, 2025 | $1.3M |
| Feb 13, 2025 | EW Edwards Lifesciences Corp | 25,500 0.00% of outstanding | $1.9M | Feb 13, 2025 | $1.0M |
| Nov 13, 2024 | EW Edwards Lifesciences Corp | 15,000 0.00% of outstanding | $984k | Nov 13, 2024 | $1.0M |
Transactions
The newest 50 of 60 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stockindirect: By Trust | -23,145 | $86.42 | $2.0M | 98,611 | May 27, 2026 |
| May 15, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock | -9,968 | $82.07 | $818k | 22,798 | May 18, 2026 |
| May 15, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stockindirect: 401(k) | -8,000 | $81.82 | $655k | 30,970 | May 18, 2026 |
| May 11, 2026 | EW Edwards Lifesciences Corp | MOption exercise Common Stock | +13,457 | $0.00 | $0 | 40,235 | May 12, 2026 |
| May 11, 2026 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -7,469 | $79.96 | $597k | 32,766 | May 12, 2026 |
| May 11, 2026 | EW Edwards Lifesciences Corp | MOption exercise Performance Rightsderivative | -13,457 | $0.00 | $0 | 0 | May 12, 2026 |
| May 7, 2026 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +7,850 | $0.00 | $0 | 28,647 | May 8, 2026 |
| May 7, 2026 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -831 | $83.20 | $69k | 27,816 | May 8, 2026 |
| May 8, 2026 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -1,038 | $82.76 | $86k | 26,778 | May 8, 2026 |
| May 7, 2026 | EW Edwards Lifesciences Corp | AGrant or award Employee Stock Option (Right to Acquire)derivative | +44,000 | $0.00 | $0 | 44,000 | May 8, 2026 |
| May 7, 2026 | EW Edwards Lifesciences Corp | AGrant or award Performance Rightsderivative | +7,850 | $0.00 | $0 | 7,850 | May 8, 2026 |
| May 3, 2026 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -469 | $83.98 | $39k | 20,797 | May 4, 2026 |
| Apr 2, 2026 | EW Edwards Lifesciences Corp | MOption exercise Common Stock10b5-1 | +22,680 | $59.26 | $1.3M | 43,946 | Apr 2, 2026 |
| Apr 2, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -4,676 | $80.59 | $377k | 39,270 | Apr 2, 2026 |
| Apr 2, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -18,004 | $80.05 | $1.4M | 21,266 | Apr 2, 2026 |
| Apr 2, 2026 | EW Edwards Lifesciences Corp | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -22,680 | $0.00 | $0 | 0 | Apr 2, 2026 |
| Mar 2, 2026 | EW Edwards Lifesciences Corp | MOption exercise Common Stock10b5-1 | +11,340 | $59.26 | $672k | 32,606 | Mar 2, 2026 |
| Mar 2, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -11,340 | $85.93 | $974k | 21,266 | Mar 2, 2026 |
| Mar 2, 2026 | EW Edwards Lifesciences Corp | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -11,340 | $0.00 | $0 | 22,680 | Mar 2, 2026 |
| Feb 25, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock | -24,000 | $83.84 | $2.0M | 21,266 | Feb 26, 2026 |
| Jan 6, 2026 | EW Edwards Lifesciences Corp | MOption exercise Common Stock10b5-1 | +11,340 | $59.26 | $672k | 43,210 | Jan 6, 2026 |
| Jan 6, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -2,632 | $84.62 | $223k | 40,578 | Jan 6, 2026 |
| Jan 6, 2026 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -8,708 | $85.98 | $749k | 31,870 | Jan 6, 2026 |
| Jan 6, 2026 | EW Edwards Lifesciences Corp | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -11,340 | $0.00 | $0 | 34,020 | Jan 6, 2026 |
| Dec 12, 2025 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock | -5,486 | $83.79 | $460k | 44,870 | Dec 12, 2025 |
| Dec 12, 2025 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock | -5,900 | $83.74 | $494k | 38,970 | Dec 12, 2025 |
| Dec 12, 2025 | EW Edwards Lifesciences Corp | GGift Common Stock | -7,100 | $0.00 | $0 | 31,870 | Dec 12, 2025 |
| Dec 10, 2025 | EW Edwards Lifesciences Corp | MOption exercise Common Stock10b5-1 | +11,340 | $59.26 | $672k | 61,696 | Dec 10, 2025 |
| Dec 10, 2025 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -11,340 | $83.83 | $951k | 50,356 | Dec 10, 2025 |
| Dec 10, 2025 | EW Edwards Lifesciences Corp | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -11,340 | $0.00 | $0 | 45,360 | Dec 10, 2025 |
| Jun 2, 2025 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -2,570 | $77.40 | $199k | 50,356 | Jun 2, 2025 |
| May 11, 2025 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -816 | $73.68 | $60k | 52,926 | May 12, 2025 |
| May 7, 2025 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -851 | $74.92 | $64k | 45,367 | May 9, 2025 |
| May 8, 2025 | EW Edwards Lifesciences Corp | AGrant or award Common Stock | +8,375 | $0.00 | $0 | 53,742 | May 9, 2025 |
| May 8, 2025 | EW Edwards Lifesciences Corp | AGrant or award Employee Stock Option (Right to Acquire)derivative | +47,000 | $0.00 | $0 | 47,000 | May 9, 2025 |
| May 8, 2025 | EW Edwards Lifesciences Corp | AGrant or award Performance Rightsderivative | +8,375 | $0.00 | $0 | 8,375 | May 9, 2025 |
| May 3, 2025 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -480 | $75.65 | $36k | 46,726 | May 5, 2025 |
| May 4, 2025 | EW Edwards Lifesciences Corp | FTax withholding Common Stock | -508 | $75.65 | $38k | 46,218 | May 5, 2025 |
| Apr 14, 2025 | EW Edwards Lifesciences Corp | MOption exercise Common Stock10b5-1 | +9,500 | $45.28 | $430k | 56,706 | Apr 14, 2025 |
| Apr 14, 2025 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -9,500 | $69.81 | $663k | 47,206 | Apr 14, 2025 |
| Apr 14, 2025 | EW Edwards Lifesciences Corp | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -9,500 | $0.00 | $0 | 0 | Apr 14, 2025 |
| Mar 13, 2025 | EW Edwards Lifesciences Corp | MOption exercise Common Stock10b5-1 | +9,500 | $45.28 | $430k | 56,436 | Mar 13, 2025 |
| Mar 13, 2025 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -9,500 | $67.96 | $646k | 46,936 | Mar 13, 2025 |
| Mar 13, 2025 | EW Edwards Lifesciences Corp | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -9,500 | $0.00 | $0 | 9,500 | Mar 13, 2025 |
| Feb 13, 2025 | EW Edwards Lifesciences Corp | MOption exercise Common Stock10b5-1 | +6,500 | $45.28 | $294k | 53,436 | Feb 13, 2025 |
| Feb 13, 2025 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -100 | $76.26 | $7,626 | 53,336 | Feb 13, 2025 |
| Feb 13, 2025 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -6,400 | $75.74 | $485k | 46,936 | Feb 13, 2025 |
| Feb 13, 2025 | EW Edwards Lifesciences Corp | MOption exercise Employee Stock Option (Right to Acquire)derivative10b5-1 | -6,500 | $0.00 | $0 | 19,000 | Feb 13, 2025 |
| Jan 16, 2025 | EW Edwards Lifesciences Corp | MOption exercise Common Stock10b5-1 | +5,000 | $45.28 | $226k | 51,936 | Jan 16, 2025 |
| Jan 16, 2025 | EW Edwards Lifesciences Corp | SOpen-market sale Common Stock10b5-1 | -5,000 | $68.75 | $344k | 46,936 | Jan 16, 2025 |
50 of 60 rows shown.
Questions about Donald E Bobo Jr
Answered from the filings on this page, as of the latest one.
Is Donald E Bobo Jr buying or selling?
In the last 12 months Donald E Bobo Jr reported 0 open-market buys worth $0 and 8 open-market sells worth $11M on SEC Form 4; the latest was sold $2.0M of EW on May 27, 2026. Grants, option exercises and tax withholding are not counted.
How did Donald E Bobo Jr's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Donald E Bobo Jr has 0.
Where does Donald E Bobo Jr file Form 4?
Donald E Bobo Jr has filed Form 4 at EW (Edwards Lifesciences Corp) as CVP,Strategy/Corp Development. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.